- Home
- MAIA vs FORA Comparison
MAIA vs FORA Comparison
Compare MAIA & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- FORA
- Stock Information
- Founded
- MAIA 2018
- FORA 2014
- Country
- MAIA United States
- FORA United States
- Employees
- MAIA N/A
- FORA N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- FORA Computer Software: Prepackaged Software
- Sector
- MAIA Health Care
- FORA Technology
- Exchange
- MAIA Nasdaq
- FORA Nasdaq
- Market Cap
- MAIA 56.3M
- FORA 60.2M
- IPO Year
- MAIA 2022
- FORA N/A
- Fundamental
- Price
- MAIA $1.59
- FORA $2.11
- Analyst Decision
- MAIA
- FORA Strong Buy
- Analyst Count
- MAIA 0
- FORA 1
- Target Price
- MAIA N/A
- FORA $5.00
- AVG Volume (30 Days)
- MAIA 375.5K
- FORA 69.3K
- Earning Date
- MAIA 08-11-2025
- FORA 08-13-2025
- Dividend Yield
- MAIA N/A
- FORA N/A
- EPS Growth
- MAIA N/A
- FORA N/A
- EPS
- MAIA N/A
- FORA N/A
- Revenue
- MAIA N/A
- FORA $25,031,040.00
- Revenue This Year
- MAIA N/A
- FORA $47.82
- Revenue Next Year
- MAIA N/A
- FORA $10.11
- P/E Ratio
- MAIA N/A
- FORA N/A
- Revenue Growth
- MAIA N/A
- FORA 18.59
- 52 Week Low
- MAIA $1.40
- FORA $1.64
- 52 Week High
- MAIA $3.74
- FORA $4.03
- Technical
- Relative Strength Index (RSI)
- MAIA 50.99
- FORA 54.68
- Support Level
- MAIA $1.46
- FORA $2.06
- Resistance Level
- MAIA $1.65
- FORA $2.19
- Average True Range (ATR)
- MAIA 0.09
- FORA 0.17
- MACD
- MAIA 0.01
- FORA 0.02
- Stochastic Oscillator
- MAIA 43.10
- FORA 40.20
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.